What Is the Appropriate Timetable for Tailored Follow-up?
Patients with colorectal cancer at risk for developing metastases or in the long run metachronous adenomas or cancers in the bowel should be offered a follow-up programme. In such a programme, consideration has to be taken regarding patients’ co-morbidity, stage of disease and organs to check. For metastatic spread, only those with stage II and III disease, as well as those having been curatively treated for metastases, should be included, and the organs of interest are the liver and lungs. Regarding surveillance for new malignancies in the bowel, all patients irrespective of stage, who are free of disease at 5 years, should be included. The aim of the whole surveillance programme is to find recurrences or a new primary which can be treated radically.
KeywordsLocal Recurrence Circumferential Resection Margin Colonoscopy Surveillance Resected Metastasis Real Rationale
- 2.Jeffery GM, Hickey BE, Hider P (2002) Follow-up strategies for patients treated for non-metastatic colorectal cancer (Cochrane Review). In: The Cochrane Library, Issue 4. Update Software, OxfordGoogle Scholar
- 6.Quirke P, Steele R, Monson J, Grieve R, Khanna S, O’Callghan C, Sun Myint A, Bessell E, Thompson LC, Parmar M, Stephens RJ, Sebag-Montefiore D (2009) Effect of the plane of surgery achieved on local recurrence in patients operated with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTGCO16 randomised clinical trial. Lancet 373:821–828PubMedCrossRefGoogle Scholar